AI assistant
Sending…
Surrozen, Inc./DE — Director's Dealing 2021
Aug 17, 2021
34164_dirs_2021-08-16_d505c8f6-15d6-44bb-a480-9fbc1397e90c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Surrozen, Inc./DE (SRZN)
CIK: 0001824893
Period of Report: 2021-08-12
Reporting Person: Vanhove Geertrui (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-12 | Employee Stock Option (right to buy) | $10.25 | A | 36647 | Acquired | 2031-08-11 | Common Stock (36647) | Direct |
Footnotes
F1: Twenty-five percent of the shares subject to the Stock Option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
More from Surrozen, Inc./DE
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18